BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29358971)

  • 1. Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats.
    Wu Y; He F; Li Y; Wang H; Shi L; Wan Q; Ou J; Zhang X; Huang D; Xu L; Lin P; Yang G; He L; Gao J
    Evid Based Complement Alternat Med; 2017; 2017():7674240. PubMed ID: 29358971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shizhifang ameliorates pyroptosis of renal tubular epithelial cells in hyperuricemia through inhibiting NLRP3 inflammasome.
    Zhou J; Wang C; Zhang X; Wu Z; Wu Y; Li D; Gao J
    J Ethnopharmacol; 2023 Dec; 317():116777. PubMed ID: 37311502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption.
    Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J
    Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice.
    Li G; Guan C; Xu L; Wang L; Yang C; Zhao L; Zhou B; Luo C; Luan H; Jiang W; Li C; Xu Y
    Front Pharmacol; 2020; 11():584942. PubMed ID: 33192525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Na
    Xiao J; Zhang X; Fu C; Yang Q; Xie Y; Zhang Z; Ye Z
    Exp Mol Med; 2018 Mar; 50(3):e452. PubMed ID: 29497172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
    Wen L; Yang H; Ma L; Fu P
    Mol Cell Biochem; 2021 Mar; 476(3):1377-1386. PubMed ID: 33389490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.
    Wang C; Pan Y; Zhang QY; Wang FM; Kong LD
    PLoS One; 2012; 7(6):e38285. PubMed ID: 22701621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
    Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
    J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.
    Ding W; Guo H; Xu C; Wang B; Zhang M; Ding F
    Oncotarget; 2016 Apr; 7(14):17479-91. PubMed ID: 27014913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats.
    Hu QH; Zhang X; Pan Y; Li YC; Kong LD
    Biochem Pharmacol; 2012 Jul; 84(1):113-25. PubMed ID: 22426011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
    Wang R; Ma CH; Zhou F; Kong LD
    Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperuricemic effect of liquiritigenin in potassium oxonate-induced hyperuricemic rats.
    Hongyan L; Suling W; Weina Z; Yajie Z; Jie R
    Biomed Pharmacother; 2016 Dec; 84():1930-1936. PubMed ID: 27863839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid regulates NLRP3/IL-1β signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K
    Yin W; Zhou QL; OuYang SX; Chen Y; Gong YT; Liang YM
    BMC Nephrol; 2019 Aug; 20(1):319. PubMed ID: 31412804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total extract of
    Ding Z; Zhao J; Wang X; Li W; Chen C; Yong C; Zhu Y; Tian F; Liu L; Yu M; Zhou E; Gu L; Yao C; Gao K
    Front Pharmacol; 2022; 13():907980. PubMed ID: 36052125
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats.
    Ma CH; Kang LL; Ren HM; Zhang DM; Kong LD
    J Ethnopharmacol; 2015 Aug; 172():108-17. PubMed ID: 26117533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis.
    Han Y; Xu X; Tang C; Gao P; Chen X; Xiong X; Yang M; Yang S; Zhu X; Yuan S; Liu F; Xiao L; Kanwar YS; Sun L
    Redox Biol; 2018 Jun; 16():32-46. PubMed ID: 29475133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.